CXM
Sprinklr, Inc.
CXM's outlook is improving, though it still trails on the overall score.
MU
Micron Technology, Inc.
MU has the edge over CXM overall, supported by stronger valuation and stronger modeled upside.
CXM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Strong |
CXM's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
CXM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $6.65 | — |
| Cheap | 18x | $1.84 | -72% |
| Fair | 47x | $4.69 | -29% |
| Current | 67x | $6.65 | — |
| Expensive | 102x | $10.23 | +54% |
Historical ranges are pointers, not guarantees.
CXM's PE is in its expensive range at 67x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its cheap range.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU has the edge over CXM in the historical PE scenario, which offers more potential upside but is not a forecast.
CXM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CXM's earnings to grow and its profitability to improve, with its revenue holding steady.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
MU has the edge over CXM on the outlook, with more favorable revenue expectations.
CXM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.53 | +431% |
| Q3 2026 | $0.10 | -77% |
| Q2 2026 | $0.12 | -69% |
| Q1 2026 | $0.09 | -80% |
| Q4 2025 | $0.40 | +150% |
| Q3 2025 | $0.43 | +139% |
| Q2 2025 | $0.39 | +86% |
| Q1 2025 | $0.44 | +144% |
| Q4 2024 | $0.16 | +45% |
CXM's earnings per share have fallen from their peak: $0.10 over the past year, against $0.44 in early 2025.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over CXM on earnings, with more consistent year-over-year improvement.
CXM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $213.7M | +0.8% |
| Q2 2026 | $219.5M | +6.8% |
| Q1 2026 | $220.6M | +8.9% |
| Q4 2025 | $219.1M | +9.2% |
| Q3 2025 | $212M | +7.5% |
| Q2 2025 | $205.5M | +4.9% |
| Q1 2025 | $202.5M | +4.3% |
| Q4 2024 | $200.7M | +7.7% |
CXM's revenue has grown year over year every quarter since early 2021: $214M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.7% | -3 points |
| Q2 2026 | 4.8% | +5.7 points |
| Q1 2026 | 6.4% | +1.3 points |
| Q4 2025 | 5.3% | +1.3 points |
| Q3 2025 | 7.7% | +7.7 points |
| Q2 2025 | -0.8% | -3.8 points |
| Q1 2025 | 5.2% | -4.3 points |
| Q4 2024 | 3.9% | -3.1 points |
CXM's operating margin was 4.7% last quarter, down 3 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over CXM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over CXM on profitability, with a higher operating margin.
CXM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $17.8M | -48% |
| Q2 2026 | $70M | -16% |
| Q1 2026 | $20.1M | +341% |
| Q4 2025 | $19.8M | +141% |
| Q3 2025 | $34.4M | +74% |
| Q2 2025 | $83.5M | +113% |
| Q1 2025 | $4.6M | -70% |
| Q4 2024 | $8.2M | -57% |
CXM generated $128M in free cash flow over the past year, down 2.3% from the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over CXM on cash flow, with more consistent year-over-year improvement.
CXM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.6x | Net Cash |
| Q2 2026 | -2.3x | Net Cash |
| Q1 2026 | -2.8x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -3.6x | Net Cash |
| Q1 2025 | -3.4x | Net Cash |
| Q4 2024 | -1.9x | Net Cash |
CXM has the edge over MU on leverage, with a lower net debt burden relative to earnings.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
CXM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.8 | Neutral |
| Stochastic | 55.9 | Neutral |
CXM's weekly RSI is 56 (neutral) and its Stochastic is 56 (neutral).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
CXM PE vs Technology Sector
| Metric | CXM | Sector median | Relative |
|---|---|---|---|
| PE | 67x | 28x | 139% above |
| PE % | 77 | 43 | 34 pts above |
CXM is trading at 67x earnings, a 139% premium to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over CXM on valuation relative to its sector.
CXM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.05 | 9.9% above |
| 20 week MA | $6.16 | 8% above |
| 50 week MA | $6.10 | 9% above |
| 100 week MA | $7.15 | 7% below |
| 200 week MA | $9.36 | 29% below |
CXM has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 29% below its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
CXM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $20.5 | $16.0 | -22% |
| 2022 | $16.0 | $7.84 | -51% |
| 2023 | $7.84 | $12.0 | +54% |
| 2024 | $12.0 | $8.53 | -29% |
| 2025 | $8.53 | $7.72 | -9.5% |
| 2026 YTD | $7.72 | $6.65 | -14% |
CXM has finished lower in four of the last five years. It's down 14% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over CXM on returns for 2026, with the stronger performance.